It has been shown to play a part in oncogenesis, cancer progression, and the development of resistance to chemotherapy in human cancers, with multiple mutations and diverse expression patterns of TERF2IP reported in cancer contexts (34, 35). This evidence concerns the gene TERF2IP and cancer.